Teleflex Incorporated

teleflex.com

What Do They Do?

Sells vascular access catheters, interventional devices and surgical instruments to hospitals and healthcare providers.

How Do They Make Money?

Teleflex sells medical devices to hospitals, healthcare providers and distributors. Products are generally shipped from manufacturing or distribution facilities, and payment is generally due 30 days from the invoice.

revenue

Segment	Share	How money arrives
Vascular Access Sold outright	46% FY2022: 24%	Sold outright
Interventional Sold outright	33% FY2022: 16%	Sold outright
Surgical Sold outright	21% FY2022: 14%	Sold outright
Other Sold outright	0.5% FY2022: 10%	Sold outright

Who Are Their Customers?

Hospitals and healthcare providers buy directly or through distributors; the OEM business supplies other medical-device manufacturers.

Do Revenues Turn Into Profits?

No. It lost $905.6M in FY2025.

Operating income, FY2025

6% of revenue

▲ +14% vs FY2024 ($103.7M, 6%)

Net income, FY2025

−45% of revenue

▼ Now a loss vs FY2024 ($69.7M, 4%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +29%; vs $442.5M in Q2 FY2025
Net income: ▼ −19%; vs $122.6M in Q2 FY2025

Vascular share of revenue vs 51.1% in Q2 FY2025

Shrinking. Revenue fell 29% in 4 years, from $2.8B in FY2021 to $2B in FY2025, about 8% a year.

Expanded interventional products The older report described coronary and peripheral intervention products; the latest adds devices from the acquired Vascular Intervention business, including drug-coated balloons, stents and balloon catheters.

OEM business marked for sale The older report described OEM as a reportable segment supplying other medical-device manufacturers; the latest classifies OEM among the businesses being sold and presents continuing operations separately.

Revenue over time

Vascular Access Interventional Surgical Other Anesthesia Interventional urology OEM

$5B$2.5B$0

FY2021 FY2022 FY2023 FY2024 FY2025

Comments